Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $1.27M | ﹤0.01% |
50,017
-9,080
| -15% | -$228K |
|
3377
SoundThinking
SSTI
$101M
| $1.27M | ﹤0.01% |
54,932
+42,286
| +334% | +$1.37M |
|
3378
Central Garden & Pet Co Class A
CENTA
$2.41B
| $1.26M | ﹤0.01% |
57,038
-7,217
| -11% | -$144K |
|
|
CYBR
3379
DELISTED
CyberArk
CYBR
| $1.26M | ﹤0.01% |
12,646
-7,822
| -38% | -$943K |
|
3380
CALL
America Movil
AMX
$71.5B
| $1.26M | ﹤0.01% |
84,900
+48,000
| +130% | +$689K |
|
3381
CALL
Deutsche Bank
DB
$71.3B
| $1.26M | ﹤0.01% |
168,200
-27,700
| -14% | -$211K |
|
|
DMC
3382
Del Monte Corp
DMC
$1.44B
| $1.26M | ﹤0.01% |
37,000
+5,267
| +17% | +$149K |
|
3383
Editas Medicine
EDIT
$447M
| $1.26M | ﹤0.01% |
55,378
+22,979
| +71% | +$569K |
|
3384
Dr. Reddy's Laboratories
RDY
$10.2B
| $1.26M | ﹤0.01% |
165,920
+64,700
| +64% | +$481K |
|
|
FBC
3385
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.26M | ﹤0.01% |
33,698
-99
| -0.3% | -$3.48K |
|
3386
CALL
Direxion Daily Small Cap Bear 3x ETF
TZA
$211M
| $1.25M | ﹤0.01% |
334
-118
| -26% | -$449K |
|
3387
PUT
Abercrombie & Fitch
ANF
$4.98B
| $1.25M | ﹤0.01% |
80,300
-75,000
| -48% | -$1.25M |
|
|
AXDX
3388
DELISTED
Accelerate Diagnostics
AXDX
| $1.25M | ﹤0.01% |
6,738
+25
| +0.4% | +$4.83K |
|
3389
PUT
Fortinet
FTNT
$117B
| $1.25M | ﹤0.01% |
81,500
+6,500
| +9% | +$105K |
|
3390
CALL
Synchrony
SYF
$25.5B
| $1.25M | ﹤0.01% |
36,700
-9,100
| -20% | -$312K |
|
|
IBTX
3391
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.25M | ﹤0.01% |
23,739
-2,944
| -11% | -$156K |
|
3392
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$307M
| $1.25M | ﹤0.01% |
728
-56
| -7% | -$99.8K |
|
|
DX
3393
Dynex Capital
DX
$3.23B
| $1.25M | ﹤0.01% |
84,376
+68,428
| +429% | +$1.07M |
|
|
LTRPA
3394
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.25M | ﹤0.01% |
132,523
+80,069
| +153% | +$835K |
|
3395
Green Dot
GDOT
$747M
| $1.25M | ﹤0.01% |
49,364
-2,612
| -5% | -$96.7K |
|
3396
PUT
Genuine Parts
GPC
$18.6B
| $1.25M | ﹤0.01% |
12,500
+6,100
| +95% | +$585K |
|
3397
Watsco Inc
WSO
$13.6B
| $1.24M | ﹤0.01% |
7,353
-26,986
| -79% | -$4.38M |
|
3398
CALL
Lazard
LAZ
$4.29B
| $1.24M | ﹤0.01% |
35,500
+16,400
| +86% | +$581K |
|
|
NVO
3399
PUT
Novo Nordisk
NVO
$207B
| $1.24M | ﹤0.01% |
48,000
+39,600
| +471% | +$1M |
|
3400
PUT
Tyson Foods
TSN
$20.6B
| $1.24M | ﹤0.01% |
14,400
-21,500
| -60% | -$1.83M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.